Reibis et al., 2012 - Google Patents
Disparity in risk factor pattern in premature versus late-onset coronary artery disease: a survey of 15,381 patientsReibis et al., 2012
View PDF- Document ID
- 10114682003143468424
- Author
- Reibis R
- Treszl A
- Wegscheider K
- Bestehorn K
- Karmann B
- Völler H
- Publication year
- Publication venue
- Vascular health and risk management
External Links
Snippet
Background There are few data available regarding the specificity and modifiability of major cardiovascular (CV) risk factors in patients with premature versus (vs) late-onset coronary artery disease (CAD). This study was designed to analyze and compare these risk factors …
- 201000008739 coronary artery disease 0 title abstract description 62
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/01—Social networking
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Reibis et al. | Disparity in risk factor pattern in premature versus late-onset coronary artery disease: a survey of 15,381 patients | |
Pouvreau et al. | Inflammation and oxidative stress markers in diabetes and hypertension | |
van Dijk et al. | Depression and anxiety symptoms as predictors of mortality in PCI patients at 10 years of follow-up | |
Udell et al. | Outcomes of women and men with acute coronary syndrome treated with and without percutaneous coronary revascularization | |
Shalom et al. | Hidradenitis suppurativa and metabolic syndrome: a comparative cross‐sectional study of 3207 patients | |
Tanboga et al. | Determinants of angiographic thrombus burden in patients with ST-segment elevation myocardial infarction | |
Pimenta et al. | Prehypertension: epidemiology, consequences and treatment | |
Chao et al. | Hyperuricemia and the risk of ischemic stroke in patients with atrial fibrillation—could it refine clinical risk stratification in AF? | |
Ekerstad et al. | Hospitalized frail elderly patients–atrial fibrillation, anticoagulation and 12 months’ outcomes | |
Damen et al. | Reduced positive affect (anhedonia) is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry | |
Gupta et al. | International differences in in-hospital revascularization and outcomes following acute myocardial infarction: a multilevel analysis of patients in ASSENT-2 | |
Lieb et al. | Residual cardiovascular risk in individuals on blood pressure–lowering treatment | |
Neuen et al. | Neutrophil–lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients | |
Angerås et al. | Treatment pattern of contemporary dual antiplatelet therapies after acute coronary syndrome: a Swedish nationwide population-based cohort study | |
Lopes et al. | Antithrombotic therapy use at discharge and 1 year in patients with atrial fibrillation and acute stroke: results from the AVAIL Registry | |
Lin et al. | Linking cognition and frailty in middle and old age: metabolic syndrome matters | |
Moglia et al. | Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study | |
Sponder et al. | Blood and urine levels of heavy metal pollutants in female and male patients with coronary artery disease | |
Ducher et al. | Risk profile in hypertension genesis: a five-year follow-up study | |
Zibaeenejad et al. | Ten-year atherosclerosis cardiovascular disease (ASCVD) risk score and its components among an Iranian population: a cohort-based cross-sectional study | |
Bang et al. | Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study | |
Jokhadar et al. | Review of the treatment of acute coronary syndrome in elderly patients | |
Sze et al. | Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study | |
Derosa et al. | Evaluation of emerging biomarkers in cardiovascular risk stratification of hypertensive patients: a 2-year study | |
Paulin et al. | Effect of angiotensin 2 receptor blockers on chronic obstructive lung disease mortality: A retrospective cohort study |